Navigation Links
Plasma Exchange Of No Use In Multiple Myeloma

New findings published in the Annals of Internal Medicine this week have found that the standard therapy for patients who are on the verge of kidney failure is useless. //The study conducted by researchers at Lawson Health Research Institute scientists in London, Canada found that a treatment called "plasma exchange" in patients with multiple myeloma has no benefits.

This means that the money which is currently spent in the treatment of the disease could now be directed elsewhere, according to Dr. Bill Clark, principal investigator in the study. Plasma exchange currently costs $5,000 to $6,000.The procedure takes up 2.5 hours and was expected to reduce kidney damage in these patients. “It is good news in that sense," Clark said, adding that they had expected to find that this procedure would eventually reduce the need for dialysis in multiple myeloma, a cancer of the plasma cells. However, in all the 14 research centers in Canada, the researchers could find no benefit of the procedure. It also had no effect on the prevailing death or dialysis rates.

The scientists are now hoping that the treatment guidelines would be changed after the findings of their study.


'"/>




Page: 1

Related medicine news :

1. Multiple Low-energy Plasma Skin Treatments Beneficial in Reducing Facial Wrinkles
2. Low Energy Plasma Treatment Better in Reducing Wrinkles
3. Mothers Happy After Exchange Of Swapped Infants
4. Abdomen Can Help In Gas Exchange In Lung Failure
5. More than 3% of US Teens Have Exchanged Sex for Money or Drugs
6. Scottish Prisons May Get Needle Exchange Programs
7. Drug Treatment Seekers Likely to Use Needle Exchange
8. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
9. Multiple organ disease cured by genes
10. Adult stem cells in treatment for Multiple sclerosis (MS)
11. Life Quality For Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... Somerset, N.J. (PRWEB) , ... December 08, 2016 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... The PSCI was set up in 2006 as a non-profit organization to unite ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Hamilton County, is embarking on a charity drive ... specializes in finding new homes for orphaned or neglected senior dogs in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family owned ... and around the Hancock County area, is announcing the launch of a charity effort ... The Hancock County Food Pantry has worked for more than 30 years to meet ...
(Date:12/7/2016)... ... , ... Students attending Envision’s summer 2017 National Youth ... experience in an emergency medical simulation, When Care is Hours Away. This dynamic ... skills that are critical success in a future career and beyond. , The ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)...  Pennsylvania Physician General Dr. Rachel Levine ... Gary Tennis released safe prescribing guidelines ... developed with the help of a task force. ... frequently prescribed for anxiety or insomnia," said Dr. ... pain medications, benzodiazepines pose a significant risk for ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: